Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

About 61% of women who had COVID-19 experienced hair loss afterward.

More research is needed to confirm if Platelet-Rich Plasma (PRP) is effective for treating hair loss.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

A nine-year-old girl with muscle weakness and total hair loss improved with specific treatments.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Finasteride can double the risk of sexual problems like ejaculation issues, low libido, and impotence.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

Alternating treatment with two drugs could help cells in a rapid aging disease.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Using superficial temporal fascia helps prevent Frey syndrome after parotid surgery.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

Platelet-rich plasma (PRP) shows no significant benefit for bone and soft-tissue injuries or wound healing, and its effectiveness may improve with customization.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

The analysis shows the U.S. leads in tissue expansion research, mainly for breast reconstruction, with a slightly higher complication rate when using acellular dermal matrix.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.